Clearside Biomedical to Present at the 37th Annual J.P. Morgan Healthcare Conference
ALPHARETTA, Ga., Jan. 02, 2019 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that […]
ALPHARETTA, Ga., Jan. 02, 2019 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that […]
Industry-leading front-end module is at the heart of Qualcomm’s C-V2X reference design GREENSBORO, N.C., Jan. 02, 2019 (GLOBE NEWSWIRE) — […]
CALABASAS, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (NASDAQ: NTWK), a global business services and enterprise application […]
Management to Host Conference Call at 8:30 a.m. ET/5:30 a.m. PT SOUTH SAN FRANCISCO, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) […]
BASKING RIDGE, N.J., Jan. 02, 2019 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced […]
Key anticipated 2019 clinical milestones: Topline results of Ovaprene® PCT clinical trial Initiation of at-home portion of Sildenafil Cream, 3.6% […]
First immunogenicity data now expected in mid-2019 CAMBRIDGE, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), […]
LITTLE ROCK, Ark., Jan. 02, 2019 (GLOBE NEWSWIRE) — Tony Thomas, president and chief executive officer of Windstream, will speak […]
NEWARK, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing […]
— Primary Efficacy Endpoint of Change in Urinary Oxalate Excretion at Four Weeks — — URIROX-2™, Second Pivotal Phase 3 […]